Merrimack Pharma: J. P. Morgan Healthcare Conference (35th Annual J.P. Morgan Healthcare Conference, Merrimack) - Jan 14, 2017 - Anticipated data from P2 CARRIE trial (NCT02399137) for IGF-1+ metastatic front-line pancreatic cancer in 2018
Anticipated P2 data • Oncology • Pancreatic Cancer
|